In parallel, preclinical studies have shown that Nectin-4-directed ADCs can be sensitized by autophagy inhibition, with agents such as chloroquine enhancing apoptotic cell death in pancreatic and bladder cancer models [577−580]. Here, NECTIN4 is linked to urinary bladder carcinoma.